Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIORA THERAPEUTICS, INC.

Get SEC filing alerts via email and in your feed for BIORA THERAPEUTICS, INC.

BIOR BIORQ

BIORA THERAPEUTICS, INC.

About BIORA THERAPEUTICS, INC.

Biora Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative oral biotherapeutic drug-device combination platforms. Its NaviCap platform delivers targeted therapies to the gastrointestinal tract for inflammatory bowel disease, while the BioJet platform enables needle-free, systemic oral delivery of large molecules to replace injections. Biora focuses on improving patient outcomes and convenience by enhancing drug efficacy, safety, and compliance in large, underserved markets through proprietary ingestible devices and formulations.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from BIORA THERAPEUTICS, INC.

1
1
BIORA THERAPEUTICS, INC. Biora Therapeutics Reports Significant Financial Changes, Net Loss Improvement in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments